Annual Cash & Cash Equivalents
$14.62 M
+$7.59 M+107.83%
December 31, 2023
Summary
- As of February 7, 2025, SURG annual cash & cash equivalents is $14.62 million, with the most recent change of +$7.59 million (+107.83%) on December 31, 2023.
- During the last 3 years, SURG annual cash & cash equivalents has risen by +$13.95 million (+2069.45%).
- SURG annual cash & cash equivalents is now at all-time high.
Performance
SURG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$13.65 M
-$24.78 M-64.48%
September 30, 2024
Summary
- As of February 7, 2025, SURG quarterly cash and cash equivalents is $13.65 million, with the most recent change of -$24.78 million (-64.48%) on September 30, 2024.
- Over the past year, SURG quarterly cash and cash equivalents has increased by +$920.20 thousand (+7.23%).
- SURG quarterly cash and cash equivalents is now -68.21% below its all-time high of $42.95 million, reached on March 31, 2024.
Performance
SURG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SURG Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +107.8% | +7.2% |
| 3 y3 years | +2069.4% | +54.0% |
| 5 y5 years | +3188.8% | +54.0% |
SURG Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +132.7% | -68.2% | +296.5% |
| 5 y | 5-year | at high | +4126.0% | -68.2% | +3917.5% |
| alltime | all time | at high | >+9999.0% | -68.2% | -100.0% |
SurgePays Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.65 M(-64.5%) |
| Jun 2024 | - | $38.43 M(-10.5%) |
| Mar 2024 | - | $42.95 M(+193.7%) |
| Dec 2023 | $14.62 M(+107.8%) | $14.62 M(+14.9%) |
| Sep 2023 | - | $12.73 M(+145.4%) |
| Jun 2023 | - | $5.19 M(-41.5%) |
| Mar 2023 | - | $8.86 M(+26.0%) |
| Dec 2022 | $7.04 M(+12.0%) | $7.04 M(-10.9%) |
| Sep 2022 | - | $7.89 M(-9.3%) |
| Jun 2022 | - | $8.70 M(+152.8%) |
| Mar 2022 | - | $3.44 M(-45.2%) |
| Dec 2021 | $6.28 M(+832.3%) | - |
| Dec 2021 | - | $6.28 M(+888.7%) |
| Sep 2021 | - | $635.50 K(+10.6%) |
| Jun 2021 | - | $574.80 K(-64.1%) |
| Mar 2021 | - | $1.60 M(+137.8%) |
| Dec 2020 | $674.00 K(+94.8%) | $674.00 K(+60.0%) |
| Sep 2020 | - | $421.30 K(+24.0%) |
| Jun 2020 | - | $339.80 K(-22.5%) |
| Mar 2020 | - | $438.50 K(+26.7%) |
| Dec 2019 | $346.00 K(-22.2%) | $346.00 K(+140.4%) |
| Sep 2019 | - | $143.90 K(-90.0%) |
| Jun 2019 | - | $1.44 M(+1.5%) |
| Mar 2019 | - | $1.42 M(+218.6%) |
| Dec 2018 | $444.60 K(-65.1%) | $444.60 K(-68.5%) |
| Sep 2018 | - | $1.41 M(-13.4%) |
| Jun 2018 | - | $1.63 M(+567.1%) |
| Mar 2018 | - | $243.80 K(-80.9%) |
| Dec 2017 | $1.27 M(+1900.3%) | $1.27 M(+770.4%) |
| Sep 2017 | - | $146.40 K(+121.1%) |
| Jun 2017 | - | $66.20 K(-20.7%) |
| Mar 2017 | - | $83.50 K(+31.1%) |
| Dec 2016 | $63.70 K | $63.70 K(-28.6%) |
| Sep 2016 | - | $89.20 K(+41.1%) |
| Jun 2016 | - | $63.20 K(-57.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $147.10 K(+111.7%) |
| Dec 2015 | $69.50 K(>+9900.0%) | $69.50 K(-48.9%) |
| Sep 2015 | - | $136.10 K(+28.4%) |
| Jun 2015 | - | $106.00 K(>+9900.0%) |
| Jan 2015 | - | $0.00(-100.0%) |
| Oct 2014 | - | $600.00(-66.7%) |
| Jul 2014 | - | $1800.00(+500.0%) |
| Apr 2014 | $300.00(-40.0%) | $300.00(+200.0%) |
| Jan 2014 | - | $100.00(-80.0%) |
| Oct 2013 | - | $500.00(-66.7%) |
| Jul 2013 | - | $1500.00(+200.0%) |
| Apr 2013 | $500.00(+66.7%) | $500.00(-37.5%) |
| Jan 2013 | - | $800.00(+100.0%) |
| Oct 2012 | - | $400.00(+100.0%) |
| Jul 2012 | - | $200.00(-33.3%) |
| Apr 2012 | $300.00(-57.1%) | $300.00(-99.5%) |
| Jan 2012 | - | $58.70 K(+7237.5%) |
| Oct 2011 | - | $800.00(+33.3%) |
| Jul 2011 | - | $600.00(-14.3%) |
| Apr 2011 | $700.00(-76.7%) | $700.00(-22.2%) |
| Jan 2011 | - | $900.00(-55.0%) |
| Oct 2010 | - | $2000.00(+233.3%) |
| Jul 2010 | - | $600.00(-80.0%) |
| Apr 2010 | $3000.00(-89.3%) | $3000.00(+500.0%) |
| Jan 2010 | - | $500.00(-91.8%) |
| Oct 2009 | - | $6100.00(-82.6%) |
| Jul 2009 | - | $35.10 K(+25.4%) |
| Apr 2009 | $28.00 K(+1900.0%) | $28.00 K(+483.3%) |
| Jan 2009 | - | $4800.00(-85.0%) |
| Oct 2008 | - | $32.00 K(+0.6%) |
| Aug 2008 | - | $31.80 K(+2171.4%) |
| Nov 2007 | $1400.00(-98.1%) | $1400.00(-97.3%) |
| May 2007 | - | $51.10 K(-20.2%) |
| Feb 2007 | - | $64.00 K |
| Nov 2006 | $72.30 K | - |
FAQ
- What is SurgePays annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for SurgePays?
- What is SurgePays annual cash & cash equivalents year-on-year change?
- What is SurgePays quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for SurgePays?
- What is SurgePays quarterly cash and cash equivalents year-on-year change?
What is SurgePays annual cash & cash equivalents?
The current annual cash & cash equivalents of SURG is $14.62 M
What is the all time high annual cash & cash equivalents for SurgePays?
SurgePays all-time high annual cash & cash equivalents is $14.62 M
What is SurgePays annual cash & cash equivalents year-on-year change?
Over the past year, SURG annual cash & cash equivalents has changed by +$7.59 M (+107.83%)
What is SurgePays quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SURG is $13.65 M
What is the all time high quarterly cash and cash equivalents for SurgePays?
SurgePays all-time high quarterly cash and cash equivalents is $42.95 M
What is SurgePays quarterly cash and cash equivalents year-on-year change?
Over the past year, SURG quarterly cash and cash equivalents has changed by +$920.20 K (+7.23%)